Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Class of Drugs may Have Many Uses

Ivanhoe Newswire


(Ivanhoe Newswire) -- From bad menstrual pain to psychotic disorders and a lot of things in between, theres a new class of drugs called vaptons that may be able to help.

Vaptons suppress the receptors for vasopressin, a hormone that plays an important role in circulatory and water control.

Text Continues Below



The FDA has approved only one vaptan medication so far. Its called conivaptan (Vaprisol), which is used to treat patients who have low sodium. Unlike the diuretics on the market now, conivaptan gets rid of excess water without causing a loss of mineral salts, which can be dangerous. That makes it potentially beneficial in treating a variety of conditions including some types of kidney disease, diabetic nephropathy, cirrhosis and depression.

Another subclass of the vaptans has been successful in treating painful periods, Raynauds disease -- which affects blood flow to the extremities -- and can help prevent premature labor and premature birth.

Preliminary studies of vaptans also investigate the treatment of glaucoma, brain hemorrhage, inner ear disorders affecting hearing and balance and even small cell cancer associated with the lung.

Sign up for a free weekly e-mail on Medical Breakthroughs called First to Know by clicking here.

SOURCE: The Lancet, May 2008

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 5/13/2008

Related Links
 border=
From Healthscout's partner site on chronic pain, ChronicPainConnection.com
Find ways to get chronic pain relief!
Find a right treatment for your chronic pain
Join our community - your chronic pain support group.





New Features

New ADHD Site!


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map